Can Animal and In Vitro Studies Give New, Relevant Answers to Questions Concerning Mammographic Screening for Human Breast Cancer?23

1988 ◽  
Vol 74 (6) ◽  
pp. 669-674
Author(s):  
Françoise Revillion-Carette ◽  
Louis Hornez ◽  
Brigitte Vandewalle ◽  
Jean Lefebvre

An enzyme-linked immunosorbent assay (ELISA) was applied to a light protein, isolated from human breast cyst fluid (BCF) termed « gross cystic disease fluid protein - 15 Kda » (GCDFP-15), a potential differentiation marker in in vitro human breast cancer studies. The detection limits of this procedure, performed in microtiter plates, were 0.5 to 250 ng/well corresponding to 10 ng/ml to 5 ng/ml of sample or antigen solution. Possible cross-reaction with various antigens, especially those found in culture media, were investigated. The correlation coefficient between enzymoassay and radioimmunoassay was 0.978. The results showed that quantification of GCDFP-15 by ELISA is a specific and highly sensitive method. This procedure may be of interest in in vitro studies on the functional differentiation of breast cancer cells.


1990 ◽  
Vol 22 (12) ◽  
pp. 1407-1411 ◽  
Author(s):  
Nora M. Navone ◽  
Cesar F. Polo ◽  
Alberto L. Frisardi ◽  
Nelida E. Andrade ◽  
alcira M. del C. Baille

Sign in / Sign up

Export Citation Format

Share Document